Free tool
FAERS Monitor: Dexedrine Spansule
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017078 or its brand name (Dexedrine Spansule, Dextroamphetamine Sulfate). Reports on generic versions are filed under their own applications.
Reports
3,824
Serious
2,051
54% of reports
Hospitalization
567
Death reported
99
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective651
- fatigue294
- nausea258
- anxiety257
- headache231
- depression220
- insomnia193
- feeling abnormal189
- somnolence188
- weight decreased155
- pain154
- dizziness141
- off label use139
- condition aggravated124
- diarrhoea113
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 87 |
| 2005 | 98 |
| 2006 | 72 |
| 2007 | 148 |
| 2008 | 65 |
| 2009 | 66 |
| 2010 | 60 |
| 2011 | 40 |
| 2012 | 57 |
| 2013 | 55 |
| 2014 | 56 |
| 2015 | 258 |
| 2016 | 654 |
| 2017 | 262 |
| 2018 | 290 |
| 2019 | 236 |
| 2020 | 270 |
| 2021 | 147 |
| 2022 | 193 |
| 2023 | 217 |
| 2024 | 213 |
| 2025 | 173 |
| 2026 | 107 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,335 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| depressionSignal | 220 | 5.3 | 4.7 | 776 |
| somnolenceSignal | 188 | 5.1 | 4.5 | 628 |
| anxietySignal | 257 | 5.0 | 4.4 | 822 |
| feeling abnormalSignal | 189 | 4.3 | 3.8 | 488 |
| insomniaSignal | 193 | 4.0 | 3.5 | 434 |
| weight decreasedSignal | 155 | 3.1 | 2.6 | 215 |
| drug ineffectiveSignal | 651 | 2.7 | 2.5 | 752 |
| condition aggravatedSignal | 124 | 2.2 | 1.9 | 85 |
| fatigueSignal | 294 | 2.1 | 1.9 | 169 |
| headacheSignal | 231 | 2.0 | 1.8 | 123 |
| nausea | 258 | 1.8 | 1.6 | 93 |
| dizziness | 141 | 1.6 | 1.3 | 28 |
| pain | 154 | 1.4 | 1.2 | 16 |
| diarrhoea | 113 | 1.0 | 0.8 | 0 |
| off label use | 139 | 0.9 | 0.7 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.